Methamphetamine increases the hippocampal α2A-adrenergic receptor and Gαo in mice

Neuroscience Letters

Volumn 334, Issue 3, 2002, Pages 145-148

  Nishio, Masahiro ^a   Kanda, Yasunari ^a   Mizuno, Katsushige ^a   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

2 Adrenergic receptor; Ambulatory activity; Expression; G protein; Hippocampus; Methamphetamine

Indexed keywords

ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; METHAMPHETAMINE; PROTEIN SUBUNIT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BLOTTING, WESTERN; BRAIN; DENTATE GYRUS; DRUG ADMINISTRATION SCHEDULE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HETEROTRIMERIC GTP-BINDING PROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; RECEPTORS, ADRENERGIC, ALPHA-2; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 0037121580     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01033-9     Document Type: Article

References (20)

1. Beson M., Cheramy A., Feltz P., Glowinski J. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat. Brain Res. 32:1971;407-424.
2. Burnette W.N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:1981;195-203.
3. Correa-Sales C., Rabin B.C., Maze M. A hypnotic response to dexametetomidine, an alpha2-agonist, is mediated in the locus coeruleus in rats. Aneasthesiology. 76:1992;948-952.
4. Dennis T., L'Heureux R., Carter C., Scatton B.J. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release. Pharmacol. Exp. Ther. 241:1987;642-646.
5. Goto Y., O'Donnell P. Synchronous activity in the hippocampus and nucleus accumbens in vivo. J. Neurosci. 21:2001;1-5.
6. Hertel P., Fagerquist M.V., Svensson T.H. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by α2-adrenoceptor blockade. Science. 286:1999;105-107.
7. Kobilka B.K., Matsui H., Kobilka T.S., Yang F.T., Francke U., Caron M.G., Lefkowitz R.J., Regan J.W. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science. 238:1987;650-656.
8. Kuribara H., Tadokoro S. Circadian variation in susceptibility to methamphetamine after repeated administration in mice. Biochem. Behav. 20:1984;247-250.
9. Kuroki Y., Fukushima K., Kanda Y., Mizuno K., Watanabe Y. Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur. J. Neurosci. 13:2001;472-476.
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-684.
11. Mavridis M., Colpaert F.C., Millan M.J. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists. Brain Res. 562:1991;216-224.
12. Regan J.W., Kobilka T.S., Yang F.T., Caron M.G., Lefkowitz R.J., Kobilka B.K. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. USA. 85:1988;6301-6305.
13. Sallinen J., Haapalinna A., Viitamaa T., Kobilka B.K., Scheinin M. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience. 86:1998;959-965.
14. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjoholm B., Macdonald E., Pelto H.M., Leino T., Barsh G.S., Kobilka B.K., Scheinin M. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. Mol. Pharmacol. 51:1997;36-46.
15. Sanger D.J. Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine. Psychopharmacology (Berlin). 96:1988;243-249.
16. Schramm N.L., McDonald M.P., Limbird L.E. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J. Neurosci. 21:2001;4875-4882.
17. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
18. Von Voigtlander P.F., Moore K.E. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J. Pharmacol. Exp. Ther. 184:1973;542-552.
19. Weinshank R.L., Zgombick J.M., Macchi M., Adham N., Lichtblau H., Branchek T.A., Hartig P.R. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor. Mol. Pharmacol. 38:1990;681-688.
20. Wortley K.E., Hughes Z.A., Heal D.J., Stanford S.C. Comparison of changes in the extracellular concentration of noradreneline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by α2-adrenoceptors. Br. J. Pharmacol. 127:1999;1860-1866.